Published in Eur J Pharmacol on November 01, 1973
Plasma clearance of neostigmine and pyridostigmine in the dog. Br J Pharmacol (1978) 0.96
Pharmacokinetics and pharmacological effects of neostigmine in man. Br J Clin Pharmacol (1979) 0.92
Ligated renal pedicles and duration of action of neostigmine and pyridostigmine. Br J Pharmacol (1977) 0.75
Differences between the biliary excretion of tri [14C] methyl-(3-hydroxy-phenyl) ammonium iodide in Wistar and Gunn rats. Biochem J (1970) 1.52
A quantitative gas-liquid chromatographic method for the determination of neostigmine and pyridostigmine in human plasma. J Chromatogr (1976) 1.29
The removal of 14 C-edrophonium from the circulation. Br J Pharmacol (1972) 1.16
Buccal morphine--a new route for analgesia? Lancet (1985) 1.11
Excretion of 14 C-edrophonium and its metabolites in bile: role of the liver cell and the peribiliary vascular plexus. Br J Pharmacol (1972) 1.11
Plasma concentration of edrophonium in man. Clin Pharmacol Ther (1976) 1.03
The pharmacokinetics of (14C)-edrophonium in normal wistar rats and homozygous Gunn rats with ligated renal pedicles. Br J Pharmacol (1974) 1.02
Histochemical characteristics and contractile properties of the spinotrapezius muscle in the rat and the mouse. J Anat (1977) 0.97
The biliary excretion of trimethyl-14C(3-hydroxyphenyl)ammonium iodide and its metabolic products. Eur J Pharmacol (1970) 0.97
Plasma concentration and metabolism of phenoperidine in man. Br J Anaesth (1980) 0.96
Quantitative gas-liquid chromatographic method for the determination of phenoperidine in human plasma. J Chromatogr (1981) 0.96
Plasma clearance of neostigmine and pyridostigmine in the dog. Br J Pharmacol (1978) 0.96
Renal clearance of pyridostigmine in patients with myasthenia gravis. Eur Neurol (1977) 0.93
Plasma pyridostigmine levels in patients with myasthenia gravis. Clin Pharmacol Ther (1977) 0.93
Pharmacokinetics and pharmacological effects of neostigmine in man. Br J Clin Pharmacol (1979) 0.92
Plasma concentration of pyridostigmine and effects in myastenia gravis. Clin Pharmacol Ther (1977) 0.91
Biliary excretion of 14 C-edrophonium and its glucuronide metabolite in Gunn rats. Arch Int Pharmacodyn Ther (1973) 0.89
The stability of glyceryl trinitrate tablets. J Pharm Pharmacol (1970) 0.87
In vitro metabolism of neostigmine and pyridostigmine. J Pharm Pharmacol (1973) 0.85
Clearance of neostigmine from the circulation during the antagonism of neuromuscular block. Br J Anaesth (1978) 0.84
Proceedings: The relation between the plasma concentration of edrophonium, inhibition of erythrocyte acetylcholinesterase, and the facilitation of neuromuscular function in the rat. Br J Pharmacol (1975) 0.84
Differential effects of myoneural blocking drugs on neuromuscular transmission. Br J Anaesth (1980) 0.83
The effect of edrophonium on erythrocyte acetylcholinesterase and neuromuscular function in the rat. Br J Pharmacol (1976) 0.80
Differential effects of neuromuscular blocking agents on suxamethonium-induced fasciculations and myalgia. Br J Anaesth (1988) 0.80
The effect of organic anions on the biliary excretion of tri (14C) methyl-(3-hydroxyphenyl) ammonium O-glucuronide. Biochem J (1971) 0.79
The effect of codeine phosphate on the absorption of ethyl alcohol. Br J Clin Pharmacol (1975) 0.77
Kinetics of intravenous pyridostigmine in man. Br J Clin Pharmacol (1981) 0.77
Plasma concentration of pyridostigmine during the antagonism of neuromuscular block. Br J Anaesth (1983) 0.77
The biliary excretion of neostigmine in the rat. Br J Pharmacol Chemother (1966) 0.75
The excretion of hydroxyphenyltrimethylammonium in bile. Br J Pharmacol (1969) 0.75
Assessment of neuromuscular blockade by electromyography: a review. J R Soc Med (1984) 0.75
Effect of urine pH on the elimination of phenoperidine. Br J Clin Pharmacol (1983) 0.75
Chirality in anaesthesia. Anaesthesia (1992) 0.75
Biological availability and in vitro dissolution of oxytetracycline dihydrate tablets. Br J Clin Pharmacol (1974) 0.75
The relationship between the pharmacokinetics, cholinesterase inhibition and facilitation of twitch tension of the quaternary ammonium anticholinesterase drugs, neostigmine, pyridostigmine, edrophonium and 3-hydroxyphenyltrimethylammonium. Br J Pharmacol (1979) 0.75
The pharmacokinetics of pyridostigmine and 3-hydroxy-N-methylpyridinium in the rat: dose-dependent effects after portal vein administration. Br J Pharmacol (1975) 0.75
Pharmacokinetics of buccal morphine. Br J Anaesth (1990) 0.75
Bioavailability and dissolution of different formulations of oxytetracycline preparations. Br J Clin Pharmacol (1975) 0.75
Prolonged release extradural morphine. Ann R Coll Surg Engl (1985) 0.75
The measurement of red cell pH from the distribution of DMO. Experientia (1970) 0.75
Designing drugs. Br J Hosp Med (1992) 0.75
The effect of bile pigments on the excretion of 14C-trimophonium glucuronide. Eur J Pharmacol (1971) 0.75
The influence of secretin on the elimination of 14 C-endrophonium in bile. Experientia (1972) 0.75
Intracellular pH in mature and immature rabbit red cells. Q J Exp Physiol Cogn Med Sci (1970) 0.75
Elimination of phenoperidine in liver disease. Br J Anaesth (1984) 0.75
Synergy and isoboles. Br J Anaesth (1993) 0.75
In vitro synthesis of metabolites of 14C-pyridostigmine. Experientia (1974) 0.75
Postoperative analgesia with Duromorph. Br J Anaesth (1985) 0.75
Quantitative capillary column gas chromatographic method for the determination of glycopyrronium in human plasma. J Chromatogr (1984) 0.75
Intraoperative bradycardia and hypotension associated with timolol and pilocarpine eye drops. Br J Anaesth (1983) 0.75
Electromyographic assessment of neuromuscular blockade induced by atracurium. Br J Anaesth (1983) 0.75
Effect of phenobarbitone on the elimination of neostigmine and its metabolites in bile. Biochem Pharmacol (1980) 0.75
Biliary excretion of (14C) edrophonium and its glucuronide conjugate. J Pharm Pharmacol (1971) 0.75
The transport of 14C-neostigmine from plasma to bile. Biochem Pharmacol (1967) 0.75
Chirality and the mode of action of anaesthetics. Eur J Anaesthesiol (1999) 0.75
Drugs affecting administration of anaesthetics. Br Dent J (1980) 0.75
Phentolamine-induced hyperglycaemia in the rabbit. Arch Int Pharmacodyn Ther (1969) 0.75
Plasma concentration and pharmacological effects of pyridostigmine in patients with myasthenia gravis [proceedings]. Br J Clin Pharmacol (1977) 0.75
The intracellular pH of the isolated perfused rat liver. Experientia (1971) 0.75
Labetalol in hypertension. Lancet (1977) 0.75
Pharmacokinetics of phenoperidine. Br J Anaesth (1986) 0.75
Infusion of secretin into the hepatic arterial circulation of the rat. J Physiol (1971) 0.75
The influence of secretion on the elimination of drugs in bile. J Physiol (1971) 0.75
Effect of antacids on the plasma concentration of phenoperidine. Br J Anaesth (1983) 0.75
Kinetics and metabolism of intramuscular neostigmine in myasthenia gravis. Clin Pharmacol Ther (1980) 0.75
The effect of adrenergic blocking agents on plasma glucose in rabbits. Eur J Pharmacol (1968) 0.75